Advertisement

Scientific Bases of PRP Therapy

  • Corey W. HunterEmail author
  • Ajax Yang
Chapter

Abstract

Platelet-rich plasma (PRP) is a minimally invasive treatment modality that harnesses the body’s own regenerative potential and focuses it on an area of need to essentially “force” the body to repair what it failed to naturally. As it pertains to the field of pain management, PRP has shown a great deal of promise with musculoskeletal injuries (i.e., tendonitis, tendon/ligament tears, etc.) that traditionally fail to heal due to poor blood supply. The appeal of PRP as an alternative treatment option for those patients who had previously exhausted conservative medical management has grown in recent years despite a complete lack of insurance coverage. In this chapter, the evidence-based rationale for using PRP to treat musculoskeletal chronic pain will be discussed.

Keywords

Platelet-rich plasma PRP Regenerative medicine Growth factors Autologous transplant 

Recommended Reading

  1. 1.
    Al-Ajlouni J, Awidi A, Samara O, et al. Safety and efficacy of autologous intra-articular platelet lysates in early and intermediate knee osteoarthrosis in humans: a prospective open-label study. Clin J Sport Med. 2015;25(6):524–8.PubMedGoogle Scholar
  2. 2.
    Alsousou J, Ali A, Willett K, Harrison P. The role of platelet-rich plasma in tissue regeneration. Platelets. 2013;24(3):173–82.PubMedCrossRefGoogle Scholar
  3. 3.
    Andia I, Maffulli N. Muscle and tendon injuries: the role of biological interventions to promote and assist healing and recovery. Arthroscopy. 2015;31(5):999–1015.PubMedCrossRefGoogle Scholar
  4. 4.
    Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91(1):4–15.PubMedCrossRefGoogle Scholar
  5. 5.
    Anitua E, Sánchez M, Zalduendo MM, et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell Prolif. 2009;42(2):162–70.PubMedCrossRefGoogle Scholar
  6. 6.
    Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 1983;258(11):7155–60.PubMedGoogle Scholar
  7. 7.
    Basso M, Cavagnaro L, Zanirato A, et al. What is the clinical evidence on regenerative medicine in intervertebral disc degeneration? Musculoskelet Surg [Internet] 2017; Available from:  https://doi.org/10.1007/s12306-017-0462-3.PubMedCrossRefGoogle Scholar
  8. 8.
    Bertrand H, Reeves KD, Bennett CJ, Bicknell S, Cheng A-L. Dextrose prolotherapy versus control injections in painful rotator cuff tendinopathy. Arch Phys Med Rehabil. 2016;97(1):17–25.PubMedCrossRefGoogle Scholar
  9. 9.
    Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012;28(3):429–39.PubMedCrossRefGoogle Scholar
  10. 10.
    Cavallo C, Filardo G, Mariani E, et al. Comparison of Platelet-Rich Plasma formulations for cartilage healing. J Bone Joint Surg Am. 2014;96(5):423–9.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Cerza F, Carnì S, Carcangiu A, et al. Comparison between hyaluronic acid and platelet-rich plasma, intra-articular infiltration in the treatment of gonarthrosis. Am J Sports Med. 2012;40(12):2822–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Chen W-H, Lo W-C, Lee J-J, et al. Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-β1 in platelet-rich plasma. J Cell Physiol. 2006;209(3):744–54.PubMedCrossRefGoogle Scholar
  13. 13.
    Cole BJ, Seroyer ST, Filardo G, Bajaj S, Fortier LA. Platelet-rich plasma: where are we now and where are we going? Sports Health. 2010;2(3):203–10.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Crane D, Everts P. Platelet rich plasma (PRP) matrix grafts. Pract Pain Manag. 2008;8(1):11–26.CrossRefGoogle Scholar
  15. 15.
    Diehl JW. Platelet-Rich plasma therapy in chronic Achilles Tendinopathy. Tech Foot Ankle Surg. 2011;10(1):2.CrossRefGoogle Scholar
  16. 16.
    Ferrari M, Zia S, Valbonesi M, et al. A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac surgery. Int J Artif Organs. 1987;10(1):47–50.PubMedCrossRefGoogle Scholar
  17. 17.
    Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari PM, Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper’s knee. Int Orthop. 2010;34(6):909–15.PubMedCrossRefGoogle Scholar
  18. 18.
    Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259–72.PubMedCrossRefGoogle Scholar
  19. 19.
    Gallin JI, Goldstein IM, Snyderman R. Inflammation: basic principles and clinical correlates. Philadelphia: Lippincott Williams & Wilkins; 1999.Google Scholar
  20. 20.
    Ganio C, Tenewitz FE, Wilson RC, Moyles BG. The treatment of chronic nonhealing wounds using autologous platelet-derived growth factors. J Foot Ankle Surg. 1993;32(3):263–8.PubMedGoogle Scholar
  21. 21.
    Golebiewska EM, Poole AW. Platelet secretion: From haemostasis to wound healing and beyond. Blood Rev. 2015;29(3):153–62.PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011;39(6):1200–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Gui K, Ren W, Yu Y, Li X, Dong J, Yin W. Inhibitory effects of platelet-rich plasma on intervertebral disc degeneration: a preclinical study in a rabbit model. Med Sci Monit. 2015;21:1368–75.PubMedPubMedCentralCrossRefGoogle Scholar
  24. 24.
    Gullung GB, Woodall JW, Tucci MA, James J, Black DA, McGuire RA. Platelet-rich plasma effects on degenerative disc disease: analysis of histology and imaging in an animal model. Evid Based Spine Care J. 2011;2(4):13–8.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Hamilton B, Tol JL, Knez W, Chalabi H. Exercise and the platelet activator calcium chloride both influence the growth factor content of platelet-rich plasma (PRP): overlooked biochemical factors that could influence PRP treatment. Br J Sports Med. 2015;49(14):957–60.PubMedCrossRefGoogle Scholar
  26. 26.
    Heldin CH, Westermark B, Wasteson A. Platelet-derived growth factor. Isolation by a large-scale procedure and analysis of subunit composition. Biochem J. 1981;193(3):907–13.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Hohaus C, Ganey TM, Minkus Y, Meisel HJ. Cell transplantation in lumbar spine disc degeneration disease. Eur Spine J. 2008;17(Suppl 4):492–503.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Jang S-J, Kim J-D, Cha S-S. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol. 2013;23(5):573–80.PubMedCrossRefGoogle Scholar
  29. 29.
    Karey KP, Sirbasku DA. Human platelet-derived mitogens. II. Subcellular localization of insulinlike growth factor I to the alpha-granule and release in response to thrombin. Blood. 1989;74(3):1093–100.PubMedCrossRefGoogle Scholar
  30. 30.
    Kepler CK, Anderson DG, Tannoury C, Ponnappan RK. Intervertebral disk degeneration and emerging biologic treatments. J Am Acad Orthop Surg. 2011;19(9):543–53.PubMedCrossRefGoogle Scholar
  31. 31.
    Kevy S, Jacobson M. Preparation of growth factors enriched autologous platelet gel (2001) Proceedings of the 27 th Annual Meeting of Service Biomaterials. April [Links].Google Scholar
  32. 32.
    Knighton DR, Ciresi K, Fiegel VD, Schumerth S, Butler E, Cerra F. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet. 1990;170(1):56–60.PubMedGoogle Scholar
  33. 33.
    Kon E, Mandelbaum B, Buda R, et al. Platelet-Rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy. 2011;27(11):1490–501.PubMedCrossRefGoogle Scholar
  34. 34.
    Li J, Chen J, Kirsner R. Pathophysiology of acute wound healing. Clin Dermatol. 2007;25(1):9–18.PubMedCrossRefGoogle Scholar
  35. 35.
    Lind M. Growth factor stimulation of bone healing. Effects on osteoblasts, osteotomies, and implants fixation. Acta Orthop Scand Suppl. 1998;283:2–37.PubMedGoogle Scholar
  36. 36.
    Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62(4):489–96.PubMedCrossRefGoogle Scholar
  37. 37.
    Middleton KK, Barro V, Muller B, Terada S, Fu FH. Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soft tissue injuries. Iowa Orthop J. 2012;32:150–63.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Möhle R, Green D, Moore MAS, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci. 1997;94(2):663–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Nagae M, Ikeda T, Mikami Y, et al. Intervertebral disc regeneration using platelet-rich plasma and biodegradable gelatin hydrogel microspheres. Tissue Eng. 2007;13(1):147–58.PubMedCrossRefGoogle Scholar
  40. 40.
    Nguyen RT, Borg-Stein J, McInnis K. Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R. 2011;3(3):226–50.PubMedCrossRefGoogle Scholar
  41. 41.
    Niemansburg SL, van Delden JJM, Oner FC, Dhert WJA, Bredenoord AL. Ethical implications of regenerative medicine in orthopedics: an empirical study with surgeons and scientists in the field. Spine J. 2014;14(6):1029–35.PubMedCrossRefGoogle Scholar
  42. 42.
    Patel S, Dhillon MS, Aggarwal S, Marwaha N, Jain A. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med. 2013;41(2):356–64.PubMedCrossRefGoogle Scholar
  43. 43.
    Peebooms J, et al. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial. Am J Sports Med. 2009;38(2):255–62.CrossRefGoogle Scholar
  44. 44.
    Pourcho AM, Smith J, Wisniewski SJ, Sellon JL. Intraarticular platelet-rich plasma injection in the treatment of knee osteoarthritis: review and recommendations. Am J Phys Med Rehabil. 2014;93(11 Suppl 3):S108–21.PubMedCrossRefGoogle Scholar
  45. 45.
    Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8(11):1227–34.PubMedCrossRefGoogle Scholar
  46. 46.
    Sadoghi P, Lohberger B, Aigner B, et al. Effect of platelet-rich plasma on the biologic activity of the human rotator-cuff fibroblasts: a controlled in vitro study. J Orthop Res. 2013;31(8):1249–53.PubMedCrossRefGoogle Scholar
  47. 47.
    Sánchez M, Fiz N, Azofra J, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy. 2012;28(8):1070–8.PubMedCrossRefGoogle Scholar
  48. 48.
    Sawamura K, Ikeda T, Nagae M, et al. Characterization of in vivo effects of platelet-rich plasma and biodegradable gelatin hydrogel microspheres on degenerated intervertebral discs. Tissue Eng Part A. 2009;15(12):3719–27.PubMedCrossRefGoogle Scholar
  49. 49.
    Serhan CN, Ward PA, Gilroy DW. Fundamentals of inflammation: Cambridge University Press; 2010.Google Scholar
  50. 50.
    Sun Y, Feng Y, Zhang CQ, Chen SB, Cheng XG. The regenerative effect of platelet-rich plasma on healing in large osteochondral defects. Int Orthop. 2010;34(4):589–97.PubMedCrossRefGoogle Scholar
  51. 51.
    Tetschke E, Rudolf M, Lohmann CH, Stärke C. Autologous proliferative therapies in recalcitrant lateral epicondylitis. Am J Phys Med Rehabil. 2015;94(9):696–706.PubMedCrossRefGoogle Scholar
  52. 52.
    Thanasas C, Papadimitriou G, Charalambidis C, Paraskevopoulos I, Papanikolaou A. Platelet-rich plasma versus autologous whole blood for the treatment of chronic lateral elbow epicondylitis: a randomized controlled clinical trial. Am J Sports Med. 2011;39(10):2130–4.PubMedCrossRefGoogle Scholar
  53. 53.
    Tinsley BA, Ferreira JV, Dukas AG, Mazzocca AD. Platelet-Rich plasma nonoperative injection therapy—a review of indications and evidence. Oper Tech Sports Med. 2012;20(2):192–200.CrossRefGoogle Scholar
  54. 54.
    Tozum TF, Demiralp B. Platelet-rich plasma: a promising innovation in dentistry. J Can Dent Assoc. 2003;69(10):664–5.PubMedGoogle Scholar
  55. 55.
    Vora A, Borg-Stein J, Nguyen RT. Regenerative injection therapy for osteoarthritis: fundamental concepts and evidence-based review. PM R. 2012;4(5 Suppl):S104–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Walter JB, Israel MS. General Pathology. 6th ed. Edinburg: Churchill Livingstone; 1987. p. 151–3.Google Scholar
  57. 57.
    Weibrich G, Hansen T, Kleis W, Buch R, Hitzler WE. Effect of platelet concentration in platelet-rich plasma on peri-implant bone regeneration. Bone. 2004;34(4):665–71.PubMedCrossRefGoogle Scholar
  58. 58.
    Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997;55(11):1294–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Wroblewski AP, Mejia HA, Wright VJ. Application of Platelet-Rich plasma to enhance tissue repair. Oper Tech Orthop 2010/6;20(2):98–105.CrossRefGoogle Scholar
  60. 60.
    Wu J, Du Z, Lv Y, et al. A new technique for the treatment of Lumbar Facet joint syndrome using intra-articular injection with autologous Platelet Rich plasma. Pain Physician. 2016;19(8):617–25.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Rehabilitation MedicineIcahn School of Medicine at Mount SinaiNew YorkUSA
  2. 2.Ainsworth Institute of Pain ManagementNew YorkUSA

Personalised recommendations